Sage Journals: Discover world-class research

Free access

Research article

First published 2008-8

Effect of Nucleoside and Nucleotide Reverse Transcriptase Inhibitors of HIV on Endogenous Nucleotide Pools

Jennifer E Vela, Michael D Miller, Gerald R Rhodes [...]

Antiviral Therapy

Free access

Review article

First published 2003-8

Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors: A Clinical Review of Antiretroviral Resistance

Joel E Gallant, Peter Z Gerondelis, Mark A Wainberg [...]

Antiviral Therapy

Free access

Research article

First published 2014-10

A Systematic Review of a Single-Class Maintenance Strategy with Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Hiv/Aids

Herman G Sprenger, Wouter FW Bierman, Tjip S van der Werf [...]

Antiviral Therapy

Free access

Review article

First published 2010-8

Clinical perspective on antiretroviral drug–drug interactions with the non-nucleoside reverse transcriptase inhibitor etravirine

Thomas N Kakuda, Monika Schöller-Gyüre, Richard MW Hoetelmans

Antiviral Therapy

Retricted access

Research article

First published 2011-01

Effect of Nucleoside and Nucleotide Analog Reverse Transcriptase Inhibitors on Cell-Mediated Immune Functions

Laura Enomoto, Peter L. Anderson, Shaobing Li [...]

AIDS Research and Human Retroviruses

Free access

Review article

First published 2005-1

Challenges for the Clinical Development of New Nucleoside Reverse Transcriptase Inhibitors for HIV Infection

Mark A Wainberg, James PC Sawyer, Julio SG Montaner [...]

Antiviral Therapy

Free access

Research article

First published 2021-11

Long-term safety and efficacy of rilpivirine in combination with nucleoside/nucleotide reverse transcriptase inhibitors in HIV-1 infected patients: 336-week rollover study of phase 2b and 3 clinical studies

Jean Michel Molina, Luminita Ene, Pedro Cahn [...]

Antiviral Therapy

Open access

Research article

First published 2022-4

Efficacy of second-line dolutegravir plus 2 nucleoside reverse transcriptase inhibitors by baseline nucleoside reverse transcriptase inhibitor resistance and nucleoside reverse transcriptase inhibitor use in the DAWNING study

Dannae Brown, Richard Kaplan, Marcelo Losso [...]

Antiviral Therapy

Retricted access

Review article

First published 2003-02

Non-nucleoside reverse transcriptase inhibitors—an overview

International Journal of STD & AIDS

Retricted access

Research article

First published 1998-12

Abacavir: A New Nucleoside Reverse Transcriptase Inhibitor

Newton G. Osborne

Journal of Gynecologic Surgery

Search results